Gene · 51548
Papers4,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human proteome-wide molecular interaction analysis based on AlphaFold3 to evaluate toxicity between PFOS and its alternative F-53B. | Toxicology | 2026 | 41093098 | PubTator, text mining | PubMed |
| Mitigation of renal tubular injury by SIRT6 may improve individual outcomes in diabetic kidney disease-potential mechanisms involving epigenetic repression of inflammatory responses. | J Adv Res | 2026 | 41076119 | PubTator, text mining | PubMed |
| Design and synthesis of guanidino derivatives of benzoate esters as SIRT6 inhibitors. | Bioorg Med Chem Lett | 2026 | 41061899 | PubTator, text mining | PubMed |
| Sirtuin 6 mitigates thoracic aortic aneurysm progression via maintenance of mitochondria homeostasis in vascular smooth muscle cells. | Acta Pharmacol Sin | 2026 | 40897853 | PubTator, text mining | PubMed |
| Mechanistic basis of N-terminal domain-mediated allostery in SIRT6: integrating molecular dynamics simulations and biochemical assays. | Mol Divers | 2026 | 40885886 | PubTator, text mining | PubMed |
| Structure-based cheminformatics and molecular dynamics profiling of potential SIRT6 inhibitors. | Mol Divers | 2026 | 40650732 | PubTator, text mining | PubMed |
| Role of histone deacetylases and sirtuins in the ischaemic stroke: a systematic review and meta-analysis of animal studies. | Stroke Vasc Neurol | 2026 | 40341167 | PubTator, text mining | PubMed |
| Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing. | Eur J Pharmacol | 2025 | 42640698 | PubTator, text mining | PubMed |
| METTL3-mediated miR-4534 maturation promotes IVDD progression by targeting the Sirt6-mediated Nrf2/HO-1 pathway. | Arch Med Sci | 2025 | 41684575 | PubTator, text mining | PubMed |
| From ketogenic metabolism to targeted therapeutics: current advances in β-hydroxybutyrylation. | Front Immunol | 2025 | 41624834 | PubTator, text mining | PubMed |
| Human molecular mechanisms of lumbar disc degeneration: A scoping review. | Spine Open | 2025 | 41585630 | PubTator, text mining | PubMed |
| Aging and lung diseases: Unraveling mechanisms and therapeutic targets. | Chin Med J Pulm Crit Care Med | 2025 | 41551014 | PubTator, text mining | PubMed |
| Mechanism and treatment of Sirtuin family in vascular calcification. | Front Cardiovasc Med | 2025 | 41480421 | PubTator, text mining | PubMed |
| Inhibitory Effect of Sirtuin6 on EndMT by Regulating Oxidative Stress and Autophagy in Coxsackievirus B3-Induced Cardiac Endothelial Cells. | Immun Inflamm Dis | 2025 | 41466491 | PubTator, text mining | PubMed |
| SIRT6 in Cancer: Mechanistic Insights into Its Dual Roles in Cancer Biology and Implications for Precision Therapeutic Development. | Biomolecules | 2025 | 41463311 | PubTator, text mining | PubMed |
| Sirtuins and regulatory miRNAs as epigenetic determinants of empagliflozin-mediated recovery after acute myocardial infarction. | Cardiovasc Diabetol | 2025 | 41462250 | PubTator, text mining | PubMed |
| An integrated bioinformatics and multi-omics investigation of the sirtuin family to identify their prognostic importance in human cancers. | Tumour Biol | 2025 | 41439701 | PubTator, text mining | PubMed |
| PCSK9 inhibition ameliorates microplastic-induced endothelial redox imbalance via SIRT6 modulation. | Cell Mol Biol Lett | 2025 | 41430105 | PubTator, text mining | PubMed |
| Sirtuins and tumor immunity: mechanistic insights, immunotherapy prospects, and therapeutic horizons. | Front Immunol | 2025 | 41425553 | PubTator, text mining | PubMed |
| Ribosomal protein RPL7A modulates lung adenocarcinoma progression via circRANBP17-UPF1-mediated SIRT6 degradation. | Cell Mol Biol Lett | 2025 | 41372808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51548/papers?page=8